Mammography

The Breast Suite software reportedly provides automated localization of regions of interest on mammograms as well as AI-enabled assessments of breast density and stratification of breast cancer risk for up to two years.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in November 2025.

The combination of deep learning and iterative reconstruction with Pristina Recon DL may enhance image quality with digital breast tomosynthesis.

Catch up on the top AI-related news and research in radiology over the past month.

The use of radiomics for mammography may help predict the development of occult invasive cancer in women with ductal carcinoma in situ (DCIS), according to a new study.

Contrast-enhanced mammography demonstrated a 95 percent specificity rate and 83.5 percent positive predictive value for ascertaining pathologic nipple involvement, according to a new multicenter study.

Catch up on the most well-viewed breast imaging content in October 2025.

Catch up on the most-well viewed radiology content in October 2025.

In a retrospective analysis of triennial screening mammograms for 134,217 women, a deep learning model offered comparable assessment of interval breast cancer risk across differences in age and breast density.

Catch up on the top AI-related news and research in radiology over the past month.

Noting an increased incidence of false negatives in screening and diagnostic mammography, researchers found that a personal history of breast cancer was associated with over a 3.6-fold higher likelihood of false negatives.

Concordant mammography detection of breast cancer by radiologists and AI had over a threefold higher likelihood of future incidental breast cancer in comparison to positive radiologist assessment and negative AI evaluation, according to new research involving over 82,000 women.

While dynamic contrast enhanced breast MRI may help reduce biopsies for suspicious calcifications on mammograms, quantitative MRI features and diffusion-weighted imaging (DWI) may not provide additional diagnostic benefit in these cases, according to a new study.

In a recent interview, Manisha Bahl, M.D., discussed new research showing significant associations between AI detection and the histologic grade and lymph node status of breast cancer.

Catch up on the top radiology content of the past week.

In comparison to false positives with unassisted radiologist interpretations of DBT exams, AI-only false positive assessments were associated with a significantly higher total of false-positive findings as well as a 33 percent lower frequency of dense breasts, according to a new study of nearly 3,000 women who had screening DBT exams.

The Mammo Enhance Heart program combines AI detection of breast arterial calcification (BAC) on screening mammography and subsequent follow-up with a local network of cardiologists.

Catch up on the most-well viewed radiology content in September 2025.

Catch up on the top radiology content of the past week.

The combination of digital breast tomosynthesis (DBT) and molecular breast imaging (MBI) offered more than double the detection of invasive breast cancer with DBT in the first year of screening, according to a prospective study of nearly 3,000 women with dense breasts.

Catch up on the top radiology content of the past week.

Digital breast tomosynthesis (DBT) and synthesized mammography offered a true-positive recall rate of 8.4 per 1,000 women screened vs. 6.2 for digital mammography alone, according to a study involving over 99,000 women.

In light of emerging research suggesting an increased incidence of breast cancer among women under the age of 40, breast radiologists discuss what they’re seeing in practice and emphasize increased vigilance to facilitate early detection.

Catch up on the top radiology content of the past week.

In a recent interview, Zeeshan Shah, M.D., discussed the challenges of addressing rising breast imaging volume amid the radiologist shortage, the potential of emerging AI solutions for bolstering efficient triage and an increasing incidence of breast cancer presentations in younger patients.